4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-23-019722
Chief Strategy & Dev. Officer sold 60,000 shares at $26.09 ($1,565,196)
- Chief Strategy & Dev. Officer acquired 60,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2023-03-16 | Option exercise | +60,000 | $3.00 | $180,000 | 336,729 | D: show line 1 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2023-03-16 | Sale | −60,000 | $26.09 | $1,565,196 | 276,729 | D: show line 2 in the form |
| Open-market sales · 60,000 sh · avg $26.09 · $1,565,196 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2023-03-16 | Option exercise · Options (Rights to Buy) | −60,000 | 1,640,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…